Assembly Biosciences (ASMB) Cash from Investing Activities Growth (3y) (2014 - 2026)
Powered by 
Analysis
Assembly Biosciences (ASMB) Cash from Investing Activities Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 46.78% |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 66.14% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | -44.69% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | -39.73% |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | -246.81% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -53.57% |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 27.84% |
| 10 | Assembly Biosciences | 692.40 Mn | 372.04 Mn | - | -122.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -122.45% |
| Mar 31, 2026 | -36.41% |
| Dec 31, 2025 | 8.62% |
| Sep 30, 2025 | -91.61% |
| Jun 30, 2025 | 20.98% |
| Mar 31, 2025 | -41.59% |
| Dec 31, 2024 | 7.59% |
| Sep 30, 2024 | 6.86% |
| Jun 30, 2024 | 54.03% |
| Mar 31, 2024 | -1.40% |
| Dec 31, 2023 | -84.96% |
| Sep 30, 2023 | 33.49% |
| Jun 30, 2023 | -28.25% |
| Mar 31, 2023 | -21.53% |
| Dec 31, 2022 | 29.55% |
| Sep 30, 2022 | 59.00% |
| Jun 30, 2022 | -27.75% |
| Mar 31, 2022 | 42.44% |
| Dec 31, 2021 | 48.51% |
| Sep 30, 2021 | 31.48% |